Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Camila Zarate

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Frontiers in Aging Neuroscience|June 5, 2023
Systematic review of Steven Jett, Camila Boneu, Camila Zarate, et al.
Plos One|February 14, 2023
Effects of sex and APOE ε4 genotype on brain mitochondrial high-energy phosphates in midlife individuals at risk for Alzheimer's disease: A 31Phosphorus MR spectroscopy studySteven Jett, Jonathan P Dyke, Camila Boneu Yepez, et al.
Frontiers in Endocrinology|March 19, 2024
Systematic review and meta-analysis of the effects of menopause hormone therapy on cognitionCaroline Andy, Matilde Nerattini, Steven Jett, et al.
Scientific Reports|March 6, 2024
Sex-specific associations of serum cortisol with brain biomarkers of Alzheimer's riskLisa Mosconi, Schantel Williams, Caroline Carlton, et al.
Frontiers in Aging Neuroscience|November 8, 2023
Systematic review and meta-analysis of the effects of menopause hormone therapy on risk of Alzheimer's disease and dementiaMatilde Nerattini, Steven Jett, Caroline Andy, et al.
Menopause (New York, N.Y.)|March 11, 2025
Neurophysiological correlates of subjective cognitive decline in perimenopausal and postmenopausal midlife women at risk for Alzheimer's diseaseLisa Mosconi, Schantel Williams, Caroline Carlton, et al.
Frontiers in Dementia|May 22, 2024
Elevated gonadotropin levels are associated with increased biomarker risk of Alzheimer's disease in midlife womenMatilde Nerattini, Federica Rubino, Steven Jett, et al.
Plos One|January 13, 2025
Sex-specific associations of serum testosterone with gray matter volume and cerebral blood flow in midlife individuals at risk for Alzheimer's diseaseMatilde Nerattini, Schantel Williams, Caroline Andy, et al.
Scientific Reports|June 20, 2024
In vivo brain estrogen receptor density by neuroendocrine aging and relationships with cognition and symptomatologyLisa Mosconi, Matilde Nerattini, Dawn C Matthews, et al.
Research Square|March 13, 2023
In vivo Brain Estrogen Receptor Expression By Neuroendocrine Aging And Relationships With Gray Matter Volume, Bio-Energetics, and Clinical SymptomatologyLisa Mosconi, Steven Jett, Matilde Nerattini, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Frontiers in Aging Neuroscience|June 5, 2023
Systematic review of Steven Jett, Camila Boneu, Camila Zarate, et al.
Plos One|February 14, 2023
Effects of sex and APOE ε4 genotype on brain mitochondrial high-energy phosphates in midlife individuals at risk for Alzheimer's disease: A 31Phosphorus MR spectroscopy studySteven Jett, Jonathan P Dyke, Camila Boneu Yepez, et al.
Frontiers in Endocrinology|March 19, 2024
Systematic review and meta-analysis of the effects of menopause hormone therapy on cognitionCaroline Andy, Matilde Nerattini, Steven Jett, et al.
Scientific Reports|March 6, 2024
Sex-specific associations of serum cortisol with brain biomarkers of Alzheimer's riskLisa Mosconi, Schantel Williams, Caroline Carlton, et al.
Frontiers in Aging Neuroscience|November 8, 2023
Systematic review and meta-analysis of the effects of menopause hormone therapy on risk of Alzheimer's disease and dementiaMatilde Nerattini, Steven Jett, Caroline Andy, et al.
Menopause (New York, N.Y.)|March 11, 2025
Neurophysiological correlates of subjective cognitive decline in perimenopausal and postmenopausal midlife women at risk for Alzheimer's diseaseLisa Mosconi, Schantel Williams, Caroline Carlton, et al.
Frontiers in Dementia|May 22, 2024
Elevated gonadotropin levels are associated with increased biomarker risk of Alzheimer's disease in midlife womenMatilde Nerattini, Federica Rubino, Steven Jett, et al.
Plos One|January 13, 2025
Sex-specific associations of serum testosterone with gray matter volume and cerebral blood flow in midlife individuals at risk for Alzheimer's diseaseMatilde Nerattini, Schantel Williams, Caroline Andy, et al.
Scientific Reports|June 20, 2024
In vivo brain estrogen receptor density by neuroendocrine aging and relationships with cognition and symptomatologyLisa Mosconi, Matilde Nerattini, Dawn C Matthews, et al.
Research Square|March 13, 2023
In vivo Brain Estrogen Receptor Expression By Neuroendocrine Aging And Relationships With Gray Matter Volume, Bio-Energetics, and Clinical SymptomatologyLisa Mosconi, Steven Jett, Matilde Nerattini, et al.
Pageof 1